Review period ends today. We see 8 Chinext, 5 Chinext50 changes. Jiangsu Hoperun will have US$430m to buy, plus flows from CSI trackers, plus potential global flows in Feb and March. But one BIG risk.
What is covered in the Full Insight:
Introduction to ChiNext/ChiNext50 Index Rebalance
Review Methodology and Criteria
Potential Changes at the December Review
Impact of the Changes
Conclusion and Upcoming Catalysts
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.